Cargando…

Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression

BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade...

Descripción completa

Detalles Bibliográficos
Autores principales: Trautmann, Agnes, Seide, Svenja, Lipska-Ziętkiewicz, Beata S., Ozaltin, Fatih, Szczepanska, Maria, Azocar, Marta, Jankauskiene, Augustina, Zurowska, Alexandra, Caliskan, Salim, Saeed, Bassam, Morello, William, Emma, Francesco, Litwin, Mieczyslaw, Tsygin, Alexey, Fomina, Svitlana, Wasilewska, Anna, Melk, Anette, Benetti, Elisa, Gellermann, Jutta, Stajic, Natasa, Tkaczyk, Marcin, Baiko, Sergey, Prikhodina, Larisa, Csaicsich, Dagmar, Medynska, Anna, Krisam, Regina, Breitschwerdt, Heike, Schaefer, Franz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060323/
https://www.ncbi.nlm.nih.gov/pubmed/36315273
http://dx.doi.org/10.1007/s00467-022-05762-4
_version_ 1785017074387517440
author Trautmann, Agnes
Seide, Svenja
Lipska-Ziętkiewicz, Beata S.
Ozaltin, Fatih
Szczepanska, Maria
Azocar, Marta
Jankauskiene, Augustina
Zurowska, Alexandra
Caliskan, Salim
Saeed, Bassam
Morello, William
Emma, Francesco
Litwin, Mieczyslaw
Tsygin, Alexey
Fomina, Svitlana
Wasilewska, Anna
Melk, Anette
Benetti, Elisa
Gellermann, Jutta
Stajic, Natasa
Tkaczyk, Marcin
Baiko, Sergey
Prikhodina, Larisa
Csaicsich, Dagmar
Medynska, Anna
Krisam, Regina
Breitschwerdt, Heike
Schaefer, Franz
author_facet Trautmann, Agnes
Seide, Svenja
Lipska-Ziętkiewicz, Beata S.
Ozaltin, Fatih
Szczepanska, Maria
Azocar, Marta
Jankauskiene, Augustina
Zurowska, Alexandra
Caliskan, Salim
Saeed, Bassam
Morello, William
Emma, Francesco
Litwin, Mieczyslaw
Tsygin, Alexey
Fomina, Svitlana
Wasilewska, Anna
Melk, Anette
Benetti, Elisa
Gellermann, Jutta
Stajic, Natasa
Tkaczyk, Marcin
Baiko, Sergey
Prikhodina, Larisa
Csaicsich, Dagmar
Medynska, Anna
Krisam, Regina
Breitschwerdt, Heike
Schaefer, Franz
author_sort Trautmann, Agnes
collection PubMed
description BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade on proteinuria reduction. METHODS: Ninety-five pediatric patients who did not receive any IIS were identified in the PodoNet Registry. Competing risk analyses were performed on 67 patients with nephrotic-range proteinuria at disease onset to explore the cumulative rates of complete or partial remission or progression to kidney failure, stratified by underlying etiology (genetic vs. non-genetic SRNS). In addition, Cox proportional hazard analysis was performed to identify factors predicting proteinuria remission. RESULTS: Eighteen of 31 (58.1%) patients with non-genetic SRNS achieved complete remission without IIS, with a cumulative likelihood of 46.2% at 1 year and 57.7% at 2 years. Remission was sustained in 11 children, and only two progressed to kidney failure. In the genetic subgroup (n = 27), complete resolution of proteinuria occurred very rarely and was never sustained; 6 (21.7%) children progressed to kidney failure at 3 years. Almost all children (96.8%) received proteinuria-lowering renin–angiotensin–aldosterone system (RAAS) antagonist treatment. On antiproteinuric treatment, partial remission was achieved in 7 of 31 (22.6%) children with non-genetic SRNS and 9 of 27 children (33.3%) with genetic SRNS. CONCLUSION: Our results demonstrate that spontaneous complete remission can occur in a substantial fraction of children with non-genetic SRNS and milder clinical phenotype. RAAS blockade increases the likelihood of partial remission of proteinuria in all forms of SRNS. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05762-4.
format Online
Article
Text
id pubmed-10060323
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100603232023-03-31 Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression Trautmann, Agnes Seide, Svenja Lipska-Ziętkiewicz, Beata S. Ozaltin, Fatih Szczepanska, Maria Azocar, Marta Jankauskiene, Augustina Zurowska, Alexandra Caliskan, Salim Saeed, Bassam Morello, William Emma, Francesco Litwin, Mieczyslaw Tsygin, Alexey Fomina, Svitlana Wasilewska, Anna Melk, Anette Benetti, Elisa Gellermann, Jutta Stajic, Natasa Tkaczyk, Marcin Baiko, Sergey Prikhodina, Larisa Csaicsich, Dagmar Medynska, Anna Krisam, Regina Breitschwerdt, Heike Schaefer, Franz Pediatr Nephrol Original Article BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade on proteinuria reduction. METHODS: Ninety-five pediatric patients who did not receive any IIS were identified in the PodoNet Registry. Competing risk analyses were performed on 67 patients with nephrotic-range proteinuria at disease onset to explore the cumulative rates of complete or partial remission or progression to kidney failure, stratified by underlying etiology (genetic vs. non-genetic SRNS). In addition, Cox proportional hazard analysis was performed to identify factors predicting proteinuria remission. RESULTS: Eighteen of 31 (58.1%) patients with non-genetic SRNS achieved complete remission without IIS, with a cumulative likelihood of 46.2% at 1 year and 57.7% at 2 years. Remission was sustained in 11 children, and only two progressed to kidney failure. In the genetic subgroup (n = 27), complete resolution of proteinuria occurred very rarely and was never sustained; 6 (21.7%) children progressed to kidney failure at 3 years. Almost all children (96.8%) received proteinuria-lowering renin–angiotensin–aldosterone system (RAAS) antagonist treatment. On antiproteinuric treatment, partial remission was achieved in 7 of 31 (22.6%) children with non-genetic SRNS and 9 of 27 children (33.3%) with genetic SRNS. CONCLUSION: Our results demonstrate that spontaneous complete remission can occur in a substantial fraction of children with non-genetic SRNS and milder clinical phenotype. RAAS blockade increases the likelihood of partial remission of proteinuria in all forms of SRNS. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05762-4. Springer Berlin Heidelberg 2022-10-31 2023 /pmc/articles/PMC10060323/ /pubmed/36315273 http://dx.doi.org/10.1007/s00467-022-05762-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Trautmann, Agnes
Seide, Svenja
Lipska-Ziętkiewicz, Beata S.
Ozaltin, Fatih
Szczepanska, Maria
Azocar, Marta
Jankauskiene, Augustina
Zurowska, Alexandra
Caliskan, Salim
Saeed, Bassam
Morello, William
Emma, Francesco
Litwin, Mieczyslaw
Tsygin, Alexey
Fomina, Svitlana
Wasilewska, Anna
Melk, Anette
Benetti, Elisa
Gellermann, Jutta
Stajic, Natasa
Tkaczyk, Marcin
Baiko, Sergey
Prikhodina, Larisa
Csaicsich, Dagmar
Medynska, Anna
Krisam, Regina
Breitschwerdt, Heike
Schaefer, Franz
Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title_full Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title_fullStr Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title_full_unstemmed Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title_short Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
title_sort outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060323/
https://www.ncbi.nlm.nih.gov/pubmed/36315273
http://dx.doi.org/10.1007/s00467-022-05762-4
work_keys_str_mv AT trautmannagnes outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT seidesvenja outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT lipskazietkiewiczbeatas outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT ozaltinfatih outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT szczepanskamaria outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT azocarmarta outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT jankauskieneaugustina outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT zurowskaalexandra outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT caliskansalim outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT saeedbassam outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT morellowilliam outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT emmafrancesco outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT litwinmieczyslaw outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT tsyginalexey outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT fominasvitlana outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT wasilewskaanna outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT melkanette outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT benettielisa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT gellermannjutta outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT stajicnatasa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT tkaczykmarcin outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT baikosergey outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT prikhodinalarisa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT csaicsichdagmar outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT medynskaanna outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT krisamregina outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT breitschwerdtheike outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT schaeferfranz outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression
AT outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression